Sotagliflozin, a drug recently approved by the Food and Drug Administration to treat type 2 diabetes and kidney disease with additional cardiovascular risk factors, can significantly reduce heart ...
A new study suggests that the benefits of prescribing anticoagulation drugs to certain older people outweigh the potential risks.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback